Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Genetic changes in the PTEN gene and their association with breast cancer in Pakistan.

Baig RM, Mahjabeen I, Sabir M, Masood N, Hafeez S, Malik FA, Kayani MA.

Asian Pac J Cancer Prev. 2011;12(10):2773-8.

PMID:
22320991
[PubMed - indexed for MEDLINE]
Free Article
2.

Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.

Figer A, Kaplan A, Frydman M, Lev D, Paswell J, Papa MZ, Goldman B, Friedman E.

Clin Genet. 2002 Oct;62(4):298-302.

PMID:
12372056
[PubMed - indexed for MEDLINE]
3.

Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers.

De Vivo I, Gertig DM, Nagase S, Hankinson SE, O'Brien R, Speizer FE, Parsons R, Hunter DJ.

J Med Genet. 2000 May;37(5):336-41.

PMID:
10807691
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.

Zhou XP, Waite KA, Pilarski R, Hampel H, Fernandez MJ, Bos C, Dasouki M, Feldman GL, Greenberg LA, Ivanovich J, Matloff E, Patterson A, Pierpont ME, Russo D, Nassif NT, Eng C.

Am J Hum Genet. 2003 Aug;73(2):404-11. Epub 2003 Jul 3.

PMID:
12844284
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, Liaw D, Caron S, Duboué B, Lin AY, Richardson AL, Bonnetblanc JM, Bressieux JM, Cabarrot-Moreau A, Chompret A, Demange L, Eeles RA, Yahanda AM, Fearon ER, Fricker JP, Gorlin RJ, Hodgson SV, Huson S, Lacombe D, Eng C, et al.

Hum Mol Genet. 1998 Mar;7(3):507-15.

PMID:
9467011
[PubMed - indexed for MEDLINE]
Free Article
6.

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.

Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI, Boyd J.

Cancer Res. 1997 Sep 1;57(17):3657-9.

PMID:
9288766
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Evaluation of germline PTEN mutations in endometrial cancer patients.

Black D, Bogomolniy F, Robson ME, Offit K, Barakat RR, Boyd J.

Gynecol Oncol. 2005 Jan;96(1):21-4.

PMID:
15589575
[PubMed - indexed for MEDLINE]
9.

Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.

Cooney KA, Tsou HC, Petty EM, Miesfeldt S, Ping XL, Gruener AC, Peacocke M.

Clin Cancer Res. 1999 Jun;5(6):1387-91.

PMID:
10389923
[PubMed - indexed for MEDLINE]
Free Article
10.

Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families.

Guénard F, Labrie Y, Ouellette G, Beauparlant CJ, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Durocher F; INHERIT BRCAs.

Fam Cancer. 2007;6(4):483-90. Epub 2007 Jul 17.

PMID:
17636424
[PubMed - indexed for MEDLINE]
11.

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.

Wang JY, Huang TJ, Chen FM, Hsieh MC, Lin SR, Hou MF, Hsieh JS.

Virchows Arch. 2003 May;442(5):437-43. Epub 2003 Apr 15.

PMID:
12695913
[PubMed - indexed for MEDLINE]
12.

PTEN mutation spectrum in breast cancers and breast hyperplasia.

Yang J, Ren Y, Wang L, Li B, Chen Y, Zhao W, Xu W, Li T, Dai F.

J Cancer Res Clin Oncol. 2010 Sep;136(9):1303-11. doi: 10.1007/s00432-010-0781-3. Epub 2010 Mar 19.

PMID:
20300775
[PubMed - indexed for MEDLINE]
13.

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients.

Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Nowakowska D, Niwinska A, Derlatka P, Cendrowski K, Kupryjanczyk J.

BMC Med Genet. 2010 Feb 2;11:20. doi: 10.1186/1471-2350-11-20.

PMID:
20122277
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.

Freihoff D, Kempe A, Beste B, Wappenschmidt B, Kreyer E, Hayashi Y, Meindl A, Krebs D, Wiestler OD, von Deimling A, Schmutzler RK.

Br J Cancer. 1999 Feb;79(5-6):754-8.

PMID:
10070865
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer.

FitzGerald MG, Marsh DJ, Wahrer D, Bell D, Caron S, Shannon KE, Ishioka C, Isselbacher KJ, Garber JE, Eng C, Haber DA.

Oncogene. 1998 Aug 13;17(6):727-31.

PMID:
9715274
[PubMed - indexed for MEDLINE]
Free Article
16.

Pharmacogenomic profiling of the PI3K/PTEN pathway in sporadic breast cancer.

Nassiri I, Faghihi M, Tavassoli M.

Iran Biomed J. 2009 Apr;13(2):79-86.

PMID:
19471547
[PubMed - indexed for MEDLINE]
17.

Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.

Haiman CA, Stram DO, Cheng I, Giorgi EE, Pooler L, Penney K, Le Marchand L, Henderson BE, Freedman ML.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1021-5.

PMID:
16702386
[PubMed - indexed for MEDLINE]
Free Article
18.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

PMID:
17010193
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.

Xie CC, Lu L, Sun J, Zheng SL, Isaacs WB, Gronberg H, Xu J.

J Hum Genet. 2011 Jul;56(7):496-502. doi: 10.1038/jhg.2011.48. Epub 2011 Jun 2.

PMID:
21633361
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mutation analysis of the DBC2 gene in sporadic and familial breast cancer.

Ohadi M, Totonchi M, Maguire P, Lindblom A, Habibi R, Alavi BA, Keyhani E, Najmabadi H.

Acta Oncol. 2007;46(6):770-2.

PMID:
17653899
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk